Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002410038 | SCV002714808 | pathogenic | Hereditary cancer-predisposing syndrome | 2021-11-29 | criteria provided, single submitter | clinical testing | The c.1804_1807dupCTAG pathogenic mutation, located in coding exon 12 of the MSH2 gene, results from a duplication of CTAG at nucleotide position 1804, causing a translational frameshift with a predicted alternate stop codon (p.D603Afs*42). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |